Pulmonx (LUNG) Accumulated Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Accumulated Expenses data on file, last reported at $14.6 million in Q4 2025.

• Quarterly Accumulated Expenses fell 11.63% year-over-year to $14.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.6 million (down 11.63% YoY) and the FY2025 annual result came in at $14.6 million, down 11.63% from the prior year.
• Accumulated Expenses slipped to $14.6 million in Q4 2025 per LUNG's latest filing, from $14.9 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $16.5 million in Q4 2024 and bottomed at $9.8 million in Q1 2021.
• The 5-year median for Accumulated Expenses is $12.6 million (2021), against an average of $12.7 million.
• The widest annual swing landed in 2021, when Accumulated Expenses soared 54.5%; it then retreated 13.17% in 2022.
• Tracing LUNG's Accumulated Expenses over 5 years: stood at $13.4 million in 2021, then declined by 0.67% to $13.3 million in 2022, then climbed by 22.28% to $16.2 million in 2023, then gained by 1.47% to $16.5 million in 2024, then fell by 11.63% to $14.6 million in 2025.
• Per Business Quant, the three latest LUNG Accumulated Expenses figures stand at $14.6 million (Q4 2025), $14.9 million (Q3 2025), and $14.4 million (Q2 2025).

Peer Comparison